Singer Jesy Nelson recently shared an emotional update regarding the complications she is experiencing in her pregnancy with twin babies. Former Little Mix singer Jesy, who is having twins with partner Zion Foster, announced that she has been diagnosed with pre-twin-to-twin transfusion syndrome (pre-TTTS). The condition, which is present in pregnancies involving twins with a shared placenta, has serious risks involved and needs intense medical supervision. As Nelson embarks on this difficult journey, her story enlightens us about a rare but dangerous condition many expectant parents may not know much about.
Twin-to-twin transfusion syndrome is a rare but dangerous condition that arises in monochorionic twin pregnancies, in which identical twins share a single placenta. The placenta supplies the developing babies with oxygen, nutrients, and blood flow, but in TTTS, there is an imbalance of blood vessels that interconnect the twins, and thus the vital resources are not evenly distributed. One twin, or the donor twin, shares excess blood with the other, referred to as the recipient twin. This leads to one baby becoming malnourished and possibly anemic, and the other in danger of heart problems due to too much blood.
Nelson described her diagnosis in a heartfelt Instagram video, explaining that she is currently in the pre-stage of TTTS and undergoing frequent monitoring. "I am being scanned twice a week, and each time, things have gotten a little worse," she shared, expressing her fears and hopes for the health of her babies.
If left untreated, TTTS can have devastating consequences. Medical research indicates that:
TTTS usually advances in stages, beginning with minimal changes in fluid levels and worsening as one twin continues to get an unequal share of blood. In extreme cases, fetal laser surgery, referred to as the Solomon technique, can be employed to divide the blood vessels and balance the twins.
Identical twins may develop differently, and their own unique form of placental sharing can have a dramatic effect on pregnancy risk. Jesy Nelson's twins are considered monochorionic diamniotic (mono/di), which means they share a placenta but have two amniotic sacs. This is the type of pregnancy in about 70% of identical twin pregnancies and carries an increased risk of complications like TTTS, umbilical cord entanglement, and growth restriction.
Conversely, dichorionic diamniotic (di/di) twins both have a separate placenta and amniotic sac, which greatly diminishes the threat of TTTS. Twin pregnancy type is normally identified by early ultrasound, with physicians being able to track future complications from inception.
Twin pregnancies, even without the presence of TTTS, entail a variety of health risks to the mother as well as infants:
Over 60% of twin pregnancies end in premature delivery, with birth usually taking place before 37 weeks. Premature infants can have immature organs and need neonatal intensive care (NICU) assistance to assist with breathing, feeding, and infection fighting.
Pregnant women with multiples are at increased risk of having high blood pressure during pregnancy. This, if left untreated, can result in preeclampsia, a serious complication of pregnancy that can result in damage to organs, preterm labor, and in some cases, maternal or fetal death.
Pregnant women carrying multiples are twice as likely to experience anemia, a condition where the body does not produce enough healthy red blood cells. This can lead to fatigue, dizziness, and complications during delivery.
According to John Hopkins Medicine, multiple birth babies are twice as likely to have congenital abnormalities compared to single births. These can include heart defects, neural tube defects, and gastrointestinal issues.
When twins have to share a placenta, they are more likely to have polyhydramnios (excess amniotic fluid) or oligohydramnios (not enough amniotic fluid). Both result in distress to the babies during fetal development and can result in premature labor.
Twins are at increased risk of excessive postpartum hemorrhage because their uterus is larger and there are greater blood supply needs.
Jesy Nelson's openness about her challenging experience is raising awareness for TTTS, a condition that few individuals—let alone expectant mothers and fathers—might be aware of. Through her tearful video, Nelson stressed the significance of knowing about twin pregnancies aside from the thrill of having multiples. "We had no idea that this type of thing occurs when you're having twins. We just desperately want to make people aware of this because there are so many people who aren't aware."
Her case reminds us of the intricacies involved in twin pregnancy and the significance of early identification and medical management. For mothers carrying twins, frequent ultrasounds and vigilance can become a life-and-death issue for early detection and better outcomes of both babies.
Through constant medical attention and care, she and her partner Zion Foster remain positive and get ready for their babies to be born. In other parents whose situations are no different, the story of Nelson highlights awareness, medical progress, and emotional encouragement in handling complicated pregnancies.
The expecting parents of twin siblings are advised to discuss TTTS screening and possible interventions with their physicians to give their babies the best chance.
Credits: Canva
Pharmacies across Britain are reporting serious shortages of a widely used medication, raising concerns that patients could face a higher risk of heart attacks and strokes. Pharmacists have described the situation as “madness,” warning that current NHS prescribing rules are stopping them from switching patients to suitable blood-thinning alternatives when aspirin is unavailable.
While aspirin is commonly taken as a pain reliever, it is also prescribed as a blood thinner. Around one-third of women and nearly 45 percent of men over the age of 65 rely on it as part of their daily medication routine.
A new survey conducted by the National Pharmacy Association (NPA), involving 540 community pharmacies across the UK, found that 86 percent are currently unable to supply aspirin. The shortage appears to be most severe for the low-dose 75mg tablets, although pharmacists report that all strengths are affected. Several pharmacies have also stopped selling aspirin over the counter due to limited stock.
As per The Independent, Olivier Picard, chair of the NPA, said pharmacists are deeply concerned about their inability to order sufficient supplies and the impact this could have on patients who depend on the drug. Low-dose aspirin, particularly the 75mg dose, is commonly prescribed for its antiplatelet effect, which helps prevent the formation of blood clots and lowers the risk of heart attacks and strokes.
Doctors often prescribe aspirin to people who have previously suffered a heart attack or stroke, experienced a transient ischaemic attack, or have conditions such as angina or peripheral arterial disease (PAD). It may also be recommended after certain types of surgery to reduce the risk of clotting.
The NPA is urging the government to reform prescribing regulations that currently prevent pharmacists from offering safe alternatives when the prescribed medicine is unavailable. Mr Picard said pharmacists have long argued for the ability to make appropriate substitutions in these situations.
He added that forcing patients to return to their GP for a revised prescription when an alternative drug is already available is not only frustrating but potentially dangerous. Delays or interruptions in treatment could lead patients to miss vital medication, increasing risks to their health.
In response to the ongoing issue, the Government has added aspirin to its export ban list in an attempt to safeguard supplies for patients in the UK.
The NPA also said pharmacists have been forced to tightly ration the remaining stock, prioritising patients with the most urgent heart conditions or those requiring emergency prescriptions.
According to the Independent Pharmacies Association, international manufacturing delays and wider supply chain disruptions are key reasons behind the shortage. The organisation also pointed to low prices negotiated by the NHS, which can make the UK a lower priority for pharmaceutical manufacturers when stock is limited.
Dr Leyla Hannbeck, chief executive of the Independent Pharmacies Association, said it is deeply concerning to see shortages affecting essential medicines such as aspirin and blood pressure treatments. She explained that while manufacturing delays play a role, pharmacies are also struggling because they cannot order the quantities they need.
She added that low reimbursement rates mean manufacturers often prioritise other countries, leaving the UK at the back of the queue. In the meantime, patients affected by shortages are advised to speak to their local pharmacist, who can offer guidance on suitable alternatives where available.
The shortage has also led to sharp price increases in pharmacies that have managed to secure supplies. The NPA said the cost of a packet of 75mg dispersible aspirin tablets has risen from 18p earlier last year to £3.90 this month.
However, the NHS reimbursement rate remains at £2.18 per packet, meaning pharmacies lose an average of £1.72 every time the medication is dispensed. Mr Picard said this is yet another sign of a pharmacy contract system that urgently needs reform.
Credits: Shreyas Talpade Instagram/Canva
Actor Shreyas Talpade recalls that during a shoot for Single Salma in Lucknow, he felt unusually drained after an intense action sequence. In an interview with the Times of India, he revealed, along with the fatigue, there was an odd sensation in his throat, something he had never experienced before. He sat down briefly, brushed it aside, and convinced himself that he was fine.
Yet, something did not sit right with him. Concerned, Shreyas decided to consult a doctor. He underwent an ECG and a 2D echo, and both reports came back normal. While he did not completely ignore what his body was telling him, he also did not probe further. He assumed the medical reports meant there was nothing to worry about.
Months later, in December 2023, Shreyas Talpade suffered a major cardiac episode, an experience that would alter his life in ways he never imagined.
Shreyas was only in his mid-40s when the incident occurred, but it changed him both physically and emotionally.
Physically, he now follows lifelong precautions to ensure such an episode does not recur. Regular medication, scheduled follow-ups, routine checkups, and strict adherence to medical advice have become a permanent part of his life.
Emotionally, the impact was even more intense. Shreyas points out that he had none of the four common risk factors associated with heart attacks. He did not smoke or drink. He was neither diabetic nor hypertensive. And yet, the cardiac episode happened.
Shreyas believes that while life brings uncertainty, many aspects of health remain within our control. After an experience like his, priorities naturally shift. Family becomes the top priority, and staying healthy becomes essential to spend meaningful time with loved ones. That, he says, means sleeping well, exercising four to five times a week, and eating nutritious meals on time.
He stresses that while nutritious food is important, eating at regular times is even more critical. Maintaining fixed meal schedules helps the body function better. Having dinner early allows the digestive system enough time to rest. Even the healthiest food, he notes, loses its benefit if meal timings are irregular.
His earlier discipline with clean eating and regular workouts played a significant role in his recovery. Shreyas also believes that post-pandemic health changes and the Covid vaccine may have triggered complications, but his active lifestyle helped him bounce back faster.
According to him, proper nutrition, regular exercise, quality sleep, and balance strengthen the body. Without these habits, the outcome could have been very different. He firmly believes the body responds to the care it receives.
Shreyas acknowledges that stress is an unavoidable part of life. However, he believes learning how to manage it is essential.
Over time, he has realised that not everything lies within one’s control. Letting go of what cannot be changed is just as important as addressing what can be managed. Wisdom often comes with age, but when someone shares their experiences, he feels it is important to listen.
His message is clear: do not wait for a personal crisis to learn lessons the hard way.
Credits: iStock and Wikimedia Commons
The United States under President Donald Trump’s administration has completed its withdrawal from the World Health Organization (WHO). The US Department of Health and Human Services confirmed the news on Thursday. This has been a longstanding goal of President Trump.
During Trump’s first term, he tried to leave WHO, then gave a notice through an executive order on the first day of his second term. It noted that the US would leave the organization. As per law, the US must give WHO a one-year notice and pay all outstanding fees before its departure. This means the US still owes WHO roughly $260 million. However, legal experts said that US is unlikely to pay up and WHO will have little recourse.
Dr. Lawrence Gostin, an expert on global health law and public health at Georgetown University told CNN, “As a matter of law, it is very clear that the United States cannot officially withdraw from WHO unless it pays its outstanding financial obligations. But WHO has no power to force the US to pay what it owes.”
WHO could pass a resolution saying that US cannot withdraw until it pays, however, it won’t risk creating any further tension that there already is.
The HHS on Thursday confirmed that all US government funding to WHO has been terminated and all personnel and contractors assigned or embedded within the organization have been recalled. It also said the US had ceased official participation in WHO-sponsored committees, leadership bodies, governance structures and technical working groups.
The US government has said it is moving ahead with its decision to exit the World Health Organization (WHO), arguing that the country has not received enough value for the money, staff, and support it has given to the global health body over the years.
Senior officials from HHS said the WHO acted against US interests, especially during the Covid-19 pandemic. They accused the organization of delaying the declaration of a global public health emergency and of praising China’s early response despite signs of underreporting, information suppression, and delays in confirming human-to-human transmission.
HHS also criticized the WHO for being slow to acknowledge airborne spread of Covid-19 and for downplaying the role of people without symptoms in spreading the virus. According to officials, these missteps cost the world precious time as the virus spread rapidly.
While the US has been the WHO’s largest funder, officials pointed out that no American has ever served as the organization’s director-general. “A promise made and a promise kept,” one senior official said, adding that US health policies should not be shaped by “unaccountable foreign bureaucrats.”
That said, the administration has not completely ruled out cooperation with the WHO. When asked whether the US would take part in an upcoming WHO meeting on next year’s flu vaccine composition, officials said discussions are still ongoing.
The government has insisted that leaving the WHO does not mean stepping away from global health leadership. Instead, the US plans to work directly with individual countries, health ministries, non-governmental organizations, and religious groups on disease surveillance and data sharing. This effort is expected to be led by the US Centers for Disease Control and Prevention’s Global Health Center. Officials have promised more announcements on this strategy in the coming months.
However, many public health experts are deeply concerned. Some warn that replacing the WHO with country-by-country agreements will create a fragmented system that lacks coordination and adequate funding. Former CDC officials note that the CDC has staff in about 60 countries, far fewer than the global reach of the WHO.
Critics say the move could leave both the US and the world vulnerable to future outbreaks. Experts argue that infectious diseases do not respect borders and that global cooperation is essential for early detection, data sharing, and rapid response.
Several health leaders have called the decision dangerous and short-sighted, warning that without WHO membership, the US could lose timely access to critical data, virus samples, and genomic information needed to develop vaccines and treatments. WHO’s director-general has described the US withdrawal as a “lose-lose” situation, saying both America and the rest of the world stand to suffer.
© 2024 Bennett, Coleman & Company Limited